ARISTOTELES

Integrating AI for Personalized Risk Assessment and Streamlined Clinical Interventions in an Integrated Care System

Prevention of development of comorbidities has been a major focus of healthcare systems. ARISTOTELES’ mission is to develop and validate an innovative AI-based approach embedded within an integrated care system, delivering personalized risk assessments and supporting targeted implementation of management strategies. 

The current healthcare landscape mainly relies on epidemiological studies and risk factor control, whereas ARISTOTELES leverages advanced causal machine learning to co-explore disease mechanisms and clinical outcomes in multimorbidity. Traditional approaches focus on established disease associations, often overlooking the intricacies of individual patient profiles. ARISTOTELES pioneers a patient-centred paradigm, offering validated AI tools that consider individual genotypes, phenotypes, lifestyle, occupational/environmental stressors, and socio-economic/behavioural factors.

ARISTOTELES has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No 101080189.